Document Detail


Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication.
MedLine Citation:
PMID:  18572363     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: This study was conducted to determine the association between the characteristics of calf muscle hemoglobin oxygen saturation (StO(2)) and exercise performance in patients with intermittent claudication.
METHODS: The study comprised 39 patients with peripheral arterial disease limited by intermittent claudication. Patients were characterized on calf muscle StO(2) before, during, and after a graded treadmill test, as well as on demographic and cardiovascular risk factors, ankle-brachial index (ABI), ischemic window, initial claudication distance (ICD), and absolute claudication distance (ACD).
RESULTS: Calf muscle StO(2) decreased 72%, from 55% +/- 18% (mean +/- SD) saturation at rest to the minimum value of 17% +/- 19% saturation attained 459 +/- 380 seconds after the initiation of exercise. After exercise, recovery half-time of calf muscle StO(2) was attained at 129 +/- 98 seconds, whereas full recovery to the resting value was reached at 225 +/- 140 seconds. After adjusting for sex, race, and grouping according to the initial decline constant in calf muscle StO(2) during exercise, the exercise time to minimum calf muscle StO(2) was correlated with the ischemic window (r = -0.493, P = .002), ICD (r = 0.339, P = .043), and ACD (r = 0.680, P < .001). After treadmill exercise, the recovery half-time of calf muscle StO(2) was correlated with the ischemic window (r = 0.531, P < .001), ICD (r = -0.598, P < .001), and ACD (r = -0.491, P = .003).
CONCLUSION: In patients limited by intermittent claudication, shorter ICD and ACD values are associated with reaching a minimum value in calf muscle StO(2) sooner during treadmill exercise and with having a delayed recovery in calf muscle StO(2) after exercise.
Authors:
Andrew W Gardner; Donald E Parker; Nykita Webb; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Related Documents :
9705093 - Should claudicants receive angioplasty or just exercise training?
9520973 - The effect of exercises on walking distance of patients with intermittent claudication:...
3490443 - Lung function and rhizopus antibodies in wood trimmers. a cross-sectional and longitudi...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-06-24
Journal Detail:
Title:  Journal of vascular surgery     Volume:  48     ISSN:  1097-6809     ISO Abbreviation:  J. Vasc. Surg.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-08-27     Completed Date:  2008-09-12     Revised Date:  2012-10-03    
Medline Journal Info:
Nlm Unique ID:  8407742     Medline TA:  J Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  644-9     Citation Subset:  IM    
Affiliation:
CMRI Metabolic Research Program, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. andrew-gardner@ouhsc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Exercise Test
Exercise Tolerance*
Female
Humans
Intermittent Claudication / etiology,  metabolism,  physiopathology*
Ischemia / etiology,  metabolism,  physiopathology*
Leg / blood supply*
Male
Middle Aged
Muscle Contraction*
Muscle, Skeletal / metabolism,  physiopathology*
Oxyhemoglobins / metabolism*
Peripheral Vascular Diseases / complications,  metabolism,  physiopathology*
Recovery of Function
Time Factors
Grant Support
ID/Acronym/Agency:
M01-RR-14467/RR/NCRR NIH HHS; R01 AG024296-01A2/AG/NIA NIH HHS; R01-AG-24296/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Oxyhemoglobins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger...
Next Document:  Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits.